Johnson & Johnson's Profits Exceeds Analysts' Expectations
Johnson & Johnson reports Q1 adjusted profit of $1.83/share
Johnson & Johnson have posted first-quarter profits of $1.83 a share, exceeding analysts' expectations of just $1.77 a share.
The company's financial report comes after Johnson & Johnson agreed to purchase the swiss biotech firm Actelion for $30 billion, a deal which is expect to lift company earnings once it closes.
This article was written by a staff member of TheStreet.
